Correlation Between Nucleus Software and Amrutanjan Health
Specify exactly 2 symbols:
By analyzing existing cross correlation between Nucleus Software Exports and Amrutanjan Health Care, you can compare the effects of market volatilities on Nucleus Software and Amrutanjan Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nucleus Software with a short position of Amrutanjan Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nucleus Software and Amrutanjan Health.
Diversification Opportunities for Nucleus Software and Amrutanjan Health
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nucleus and Amrutanjan is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Nucleus Software Exports and Amrutanjan Health Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amrutanjan Health Care and Nucleus Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nucleus Software Exports are associated (or correlated) with Amrutanjan Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amrutanjan Health Care has no effect on the direction of Nucleus Software i.e., Nucleus Software and Amrutanjan Health go up and down completely randomly.
Pair Corralation between Nucleus Software and Amrutanjan Health
Assuming the 90 days trading horizon Nucleus Software Exports is expected to generate 1.61 times more return on investment than Amrutanjan Health. However, Nucleus Software is 1.61 times more volatile than Amrutanjan Health Care. It trades about -0.07 of its potential returns per unit of risk. Amrutanjan Health Care is currently generating about -0.2 per unit of risk. If you would invest 114,120 in Nucleus Software Exports on October 11, 2024 and sell it today you would lose (3,875) from holding Nucleus Software Exports or give up 3.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nucleus Software Exports vs. Amrutanjan Health Care
Performance |
| Timeline |
| Nucleus Software Exports |
| Amrutanjan Health Care |
Nucleus Software and Amrutanjan Health Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nucleus Software and Amrutanjan Health
The main advantage of trading using opposite Nucleus Software and Amrutanjan Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nucleus Software position performs unexpectedly, Amrutanjan Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amrutanjan Health will offset losses from the drop in Amrutanjan Health's long position.| Nucleus Software vs. Ratnamani Metals Tubes | Nucleus Software vs. Apex Frozen Foods | Nucleus Software vs. Megastar Foods Limited | Nucleus Software vs. Nahar Industrial Enterprises |
| Amrutanjan Health vs. Parag Milk Foods | Amrutanjan Health vs. JB Chemicals Pharmaceuticals | Amrutanjan Health vs. Neogen Chemicals Limited | Amrutanjan Health vs. Fertilizers and Chemicals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |